Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer

T cells recognize cancer cells via human leukocyte antigen (HLA)/peptide complexes and, when disease overtakes these immune mechanisms, immunotherapy can exogenously target these same HLA/peptide surface markers. We previously identified an HLA-A2-presented peptide derived from macrophage migration...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Ther
Main Authors: Patterson, Andrea M, Kaabinejadian, Saghar, McMurtrey, Curtis P, Bardet, Wilfried, Jackson, Ken W, Zuna, Rosemary E, Husain, Sanam, Adams, Gregory P, MacDonald, Glen, Dillon, Rachelle L., Ames, Harold, Buchli, Rico, Hawkins, Oriana E, Weidanz, Jon A, Hildebrand, William H
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747837/
https://ncbi.nlm.nih.gov/pubmed/26719579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0658
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares